Pfizer Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar' 24	Dec' 23	Sep' 23	Jun' 23	Mar' 23

Sales

546.63

539.97

575.21

531.36

572.64

Operating profit

189.43

152.55

182.61

110.71

181.87

Interest

6.95

2.86

2.73

2.87

2.53

Gross profit

257.61

185.54

215.95

141.30

210.72

EPS (Rs)

39.10

28.41

32.56

20.44

28.34

Other income

75.13

35.85

36.07

33.46

31.38

Stock adjustment

6.70

-43.27

41.86

-17.11

-5.62

Raw material

88.68

77.23

83.78

86.11

70.67

Power and fuel

-

-

-

-

-

Employee expenses

75.11

89.37

89.80

93.52

65.31

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

186.71

264.09

177.16

258.13

260.41

Provisions made

-

-

-

-

-

Depreciation

13.75

17.55

15.43

15.55

26.41

Taxation

65.00

45.96

51.56

32.22

35.07

Net profit / loss

178.86

129.98

148.96

93.53

129.65

Extra ordinary item

-

7.95

-

-

-19.59

Prior year adjustments

-

-

-

-

-

Equity capital

45.75

45.75

45.75

45.75

45.75

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

34.65

28.25

31.75

20.84

31.76

GPM (%)

41.43

32.22

35.33

25.02

34.89

NPM (%)

28.77

22.57

24.37

16.56

21.46